CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
3.6. DISTRIBUTOR AND SUPPLIERS LIST

CHAPTER 4 ROMANIA IVD MARKET, BY PRODUCT

4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. REAGENTS
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast
4.3. INSTRUMENTS
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast
4.4. SOFTWARE AND SERVICES
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast

CHAPTER 5 ROMANIA IVD MARKET, BY TECHNIQUE

5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. IMMUNODIAGNOSTICS
5.2.1. Market size and forecast
5.2.2. Non-rapid tests
5.2.2.1. Market size and forecast
5.2.3. Rapid tests
5.2.3.1. Market size and forecast
5.3. HEMATOLOGY
5.3.1. Market size and forecast
5.4. MOLECULAR DIAGNOSTICS
5.4.1. Market size and forecast
5.5. TISSUE DIAGNOSTICS
5.5.1. Market size and forecast
5.6. CLINICAL CHEMISTRY
5.6.1. Market size and forecast
5.7. OTHER IVD TECHNIQUES
5.7.1. Market size and forecast

CHAPTER 6 ROMANIA HUMAN IVD MARKET, BY APPLICATION

6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. INFECTIOUS DISEASES
6.2.1. Market size and forecast
6.3. CANCER
6.3.1. Market size and forecast
6.4. CARDIAC DISEASES
6.4.1. Market size and forecast
6.5. IMMUNE SYSTEM DISORDERS
6.5.1. Market size and forecast
6.6. NEPHROLOGICAL DISEASES
6.6.1. Market size and forecast
6.7. GASTROINTESTINAL DISEASES
6.7.1. Market size and forecast
6.8. OTHER INDICATIONS
6.8.1. Market size and forecast

CHAPTER 7 ROMANIA ANIMAL IVD MARKET, BY APPLICATION

7.1. OVERVIEW
7.1.1. Market size and forecast
7.2. INFECTIOUS DISEASES
7.2.1. Market size and forecast
7.3. AUTOIMMUNE DISEASES
7.3.1. Market size and forecast
7.4. CARDIAC DISEASES
7.4.1. Market size and forecast
7.5. OTHER INDICATIONS
7.5.1. Market size and forecast

CHAPTER 8 ROMANIA IVD MARKET, BY END USER

8.1. OVERVIEW
8.1.3. Market size and forecast
8.2. STANDALONE LABORATORIES
8.2.3. Market size and forecast
8.3. HOSPITALS & CLINICS
8.3.3. Market size and forecast
8.4. ACADEMIC AND RESEARCH INSTITUTIONS
8.4.3. Market size and forecast
8.5. POINT OF CARE TESTING
8.5.3. Market size and forecast
8.5. OTHER END USER
8.5.3. Market size and forecast

CHAPTER 9 COMPANY PROFILES

9.1. ALERE INC.
9.1.1. Company overview
9.1.2. Business performance
9.1.3. Key strategies and developments
9.2. BAYER AG
9.2.1. Company overview
9.2.2. Business performance
9.2.3. Key strategies and development
9.3. BECTON DICKINSON AND COMPANY
9.3.1. Company overview
9.3.2. Business performance
9.3.3. Key strategies and development
9.4. BIOMERIEUX
9.4.1. Company overview
9.4.2. Business performance
9.4.3. Key strategies and developments
9.5. BIO-RAD LABORATORIES
9.5.1. Company overview
9.5.2. Business performance
9.5.3. Key strategies and developments
9.6. DANAHER CORPORATION
9.6.1. Company overview
9.6.2. Business performance
9.6.3. Key strategies and development
9.7. F. HOFFMANN-LA ROCHE AG
9.7.1. Company overview
9.7.2. Business performance
9.7.3. Key strategies and developments
9.8. JOHNSON & JOHNSON
9.8.1. Company overview
9.8.2. Business performance
9.8.3. Key strategies and developments
9.9. SYSMEX CORPORATION
9.9.1. Company overview
9.9.2. Business performance
9.10. THERMO FISHER SCIENTIFIC INC.
9.10.1. Company overview
9.10.2. Business performance
9.10.3. Key strategies and development